NCT00185289已完成3 期
Multi-center , Open, Uncontrolled Study to Investigate the Efficacy and Safety of a 4 Phasic Oral Contraceptive SH T00658 in a 28-day Regimen for 20 Cycles in Healthy Female Volunteers
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 1,392
- 试验地点
- 50
- 主要终点
- Number of unintended pregnancies
研究概览
简要总结
The purpose of this study is to evaluate the safety and effectiveness of a new 4-phasic preparation in the prevention of pregnancies in a large group of volunteers.
详细描述
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy volunteers
排除标准
- •Any condition that might interfere the outcomes
研究组 & 干预措施
Arm 1
Experimental
干预措施: EV/DNG (Qlaira, BAY86-5027, SH T00658K) (Drug)
结局指标
主要结局
Number of unintended pregnancies
时间窗: 20 treatment cycles each consisting of 28 days and follow-up period of 14 days
次要结局
- Adverse event collection(20 treatment cycles each consisting of 28 days)
研究者
研究点 (50)
Loading locations...
相似试验
已完成
4 期
Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).Metastatic Colorectal CancerNCT03564938Bayer100
已完成
3 期
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)Short Bowel SyndromeNCT02340819Shire11
招募中
4 期
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.End Stage Renal Disease (ESRD)NCT06597201Chengdu Qingshan Likang Pharmaceutical Co., Ltd400
已完成
4 期
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric PatientsPathological ProcessesNCT01092754Guerbet100
招募中
4 期
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock PatientsHypovolemic ShockNCT05956418Pharmazz, Inc.400
